Study results confirm ability of T-SPOT®.TB to detect tuberculosis disease in HIV infected patients
6 Apr 2010Oxford Immunotec Ltd, the T cell measurement company, has today announced the outcome of a recent study performed at the Chelsea and Westminster Hospital, London.
The results of the study which were presented to the 12th Annual Conference of the British HIV Association meeting in Brighton (29th March-April 1st) confirmed that the Company’s T-SPOT.TB test is able to detect tuberculosis in HIV patients whose immune systems are severely compromised. These data confirm previously reported results from several other studies confirming that T-SPOT.TB performs well even in patients whose CD4 T cell count is less than 200 cells/ìl. The study also confirmed the ability of T-SPOT.TB to be used as a ‘rule-out’ test for TB infection in HIV patients.
Commenting on the reported findings, Peter Wrighton-Smith, Chief Executive Officer of Oxford Immunotec said “This study confirms previously published results by other groups and firmly establishes T-SPOT.TB as the only test for latent Tuberculosis infection to have consistently demonstrated efficacy in HIV infected patients with low CD4 T cell counts”.
Related Products
Request Quote for All Products
T-SPOT®.TB
Oxford ImmunotecThe T-SPOT®.TB test is a revolutionary product that diagnoses both latent TB infection and active disease by measuring T cells that have been specifically activated by Mycobacterium tuberculosis (MTB) antigens. The T-SPOT.TB test sets new clinical standards of sensitivity and reliability. The product was licensed across Europe in July 2004 and received FDA premarket approval in July 2008. It has been designed to replace the current tuberculin skin test (Mantoux test), bringing effective TB testing to many new patient groups where the skin test gives poor or unreliable results. This revolutionary technology has been tested in many thousands of patients in all parts of the world. Studies have shown the excellent sensitivity and specificity of the T-SPOT.TB test and demonstrate its utility for the diagnosis and control of TB. The T-SPOT.TB kit is supplied with a plate containing 12 X 8 well strips. 4 wells are required for each patient sample